Probability analysis of hepatocellular carcinoma in hepatitis patients in the gray zone
The GZ group and GZ-B subgroup have a higher risk of HCC. Anti-hepatitis B virus therapy should be considered as early as possible for patients in the GZ group, especially in the GZ-B subgroup.
Authors
- Sijie Yu
- Jianna Zhang (ORCID: https://orcid.org/0000-0003-4460-022X)
- Shibo Li (ORCID: https://orcid.org/0000-0002-0147-8618)
- K. Zhu
- Yu Huang
Institutions
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Zhoushan Hospital (CN)
- Taizhou First People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2024-12-24
- DOI
- https://doi.org/10.3389/fmed.2024.1464981
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.77